kanamycin a has been researched along with isoniazid in 276 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 164 (59.42) | 18.7374 |
1990's | 14 (5.07) | 18.2507 |
2000's | 22 (7.97) | 29.6817 |
2010's | 60 (21.74) | 24.3611 |
2020's | 16 (5.80) | 2.80 |
Authors | Studies |
---|---|
Kitaura, K; Mineura, K; Murayama, Y; Nakamizo, A; Nakamizo, Y; Niino, H; Okachi, R; Ono, T | 1 |
Johansson, CB; Topcu, G; Ulubelen, A | 1 |
Sriram, D; Thirumurugan, R; Yogeeswari, P | 1 |
Keawpradub, N; Plubrukarn, A; Wonganuchitmeta, SN; Yuenyongsawad, S | 1 |
Christiansen, HC; Copp, BR; G Franzblau, S; Lindsay, BS | 1 |
Beifuss, U; Conrad, J; Klaiber, I; Leutbecher, H; Mika, S; Möller, W; Mongkolvisut, W; Rösner, H; Sutthivaiyakit, S | 1 |
Mongkolvisut, W; Sutthivaiyakit, S | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
Dettrakul, S; Kittakoop, P; Rajviroongit, S; Surerum, S | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Govender, K; Govender, P; Govender, T; Kruger, HG; Maguire, GE; Muthusamy, K; Onajole, OK; Pillay, M; van Helden, PD; Wiid, I | 1 |
Abe, C; Chiba, T; Horita, Y; Inagaki, E; Kuroishi, R; Kurono, Y; Maeda, Y; Mori, M; Nishimura, K; Onozaki, K; Takii, T; Yamamoto, Y | 1 |
Kongsaeree, P; Mongkolvisut, W; Prabpai, S; Sutthivaiyakit, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bishai, WR; Grosset, JH; Nuermberger, EL; Zhang, T | 1 |
Changtam, C; Hongmanee, P; Suksamrarn, A | 1 |
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chibale, K; Franzblau, SG; Gut, J; Little, S; Rosenthal, PJ; Tukulula, M; Wan, B | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cho, SH; Franzblau, SG; Fryling, NA; Hwang, CH; Jaki, BU; Klein, LL; Lankin, DC; McAlpine, JB; Napolitano, JG; Pauli, GF; Stamets, PE; Wang, Y | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
Brantner, A; Brun, R; Bucar, F; Faist, J; Gröblacher, B; Kaiser, M; Kalia, Y; Merino, V; Perozzo, R; Saf, R; Scapozza, L; Seebacher, W; Weis, R; Wolkinger, V | 1 |
Álvarez-Gómez, D; Álvarez-Ruíz, E; Ballell-Pages, L; Barros, D; Castro-Pichel, J; Chung, CW; Convery, MA; Encinas, L; Gobec, S; Martínez-Hoyos, M; Mendoza-Losana, A; Neu, M; Pajk, S; Pérez-Herrán, E; Šink, R; Sosič, I; Young, RJ; Živec, M | 1 |
Bhatt, K; Desai, NC; Jha, PC; Khedkar, VM; Nawale, L; Sarkar, D; Somani, H; Trivedi, A | 1 |
Arkile, MA; Sarkar, D; Shaikh, MH; Shingate, BB; Subhedar, DD; Yeware, A | 1 |
Centárová, I; Cole, ST; Čonka, P; Hrabálek, A; Karabanovich, G; Klimešová, V; Mikušová, K; Němeček, J; Pávek, P; Pávková, I; Roh, J; Šarkan, M; Smutný, T; Stolaříková, J; Székely, R; Vávrová, K; Vejsová, M; Vocat, A; Zemanová, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Chegaev, K; Chung, MC; de Souza, PC; Dos Santos, JL; Fernandes, GFDS; Fruttero, R; Guglielmo, S; Lazzarato, L; Marino, LB; Pavan, FR | 1 |
Abay, E; Axtman, M; Ballell, L; Barry, CE; Boesche, M; Boshoff, HIM; Brunschwig, C; Chibale, K; Drewes, G; Gessner, RK; Ghidelli-Disse, S; Ghorpade, SR; Gordon, R; Harris, CJ; Lafuente-Monasterio, MJ; Lawrence, N; Lelièvre, J; Mizrahi, V; Moosa, A; Mueller, R; Nchinda, A; Njoroge, M; Pflaumer, H; Rebollo-Lopez, MJ; Santos, G; Sanz, O; Seldon, R; Selenski, C; Simelane, SB; Sirgel, FA; Soares de Melo, C; Street, LJ; Taylor, D; Urones, B; van Helden, P; Warner, DF; Wilson, CR | 1 |
Alajlani, M; Bauer, R; Belaj, F; Brantner, A; Bucar, F; Faist, J; Hochegger, P; Kaiser, M; Kretschmer, N; Mäser, P; Mohsin, NU; Saf, R; Seebacher, W; Turek, I; Weis, R | 1 |
Bai, L; Deng, JL; Gao, F; Lv, ZS; Wang, Y; Xu, Z; Zhang, F; Zhao, SJ | 1 |
Chopra, S; Dusthackeer, VNA; Krishna, EV; Krishna, VS; Mahizhaveni, B; Makane, VB; Misra, S; Rode, HB; Shukla, M; Sriram, D | 1 |
Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
Bera, S; Mondal, D | 1 |
Mabhula, A; Singh, V | 1 |
Bishai, WR; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Wang, SS; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
Canaan, S; Cavalier, JF; Magrioti, V; Mallick, I; Mavrikaki, V; Pagonis, A; Poncin, I | 1 |
Chen, S; Ding, CZ; Franzblau, SG; Guo, F; Huang, Z; Li, L; Li, Y; Luo, W; Shen, L; Tang, D; Wang, B; Xu, D; Yang, M; Zhu, Y | 1 |
Bin, W; Chen, S; Ding, CZ; Franzblau, SG; Hu, Y; Huang, Z; Jiang, N; Luo, W; Shen, L; Tao, X; Wei, X; Wei, Y; Xu, D; Yang, M; Zhu, Y | 1 |
Alshabani, LA; Bhakta, S; Estrada, DF; Kumar, A; Simons, C; Srithiran, G; Willcocks, SJ | 1 |
Bates, JH | 1 |
Newton, RW | 1 |
Schröder, KH | 1 |
Hadgu, AG; Keterew, W; Pattyn, SR; Van Den Breen, L | 1 |
Iwainsky, H; Reutgen, H; Sesser, I | 1 |
Kozlova, NV; Kozulitsyna, TI | 1 |
Alberghina, M; Palermo, F | 1 |
Golenitskiĭ, AI | 1 |
Mita, R; Ottomo, M; Suzuki, S; Tamura, H | 1 |
Dall, G; Jenkin, DJ | 1 |
Grassi, C; Grassi, GG | 1 |
Cole, ST; Heym, B | 1 |
Tsukamura, M | 3 |
Holdiness, MR | 2 |
Heifets, L | 1 |
Heap, BJ | 1 |
Leat, JL; Marks, J | 1 |
Krivinka, R; Tousek, J | 1 |
Wilson, TM | 1 |
Canetti, G; Gay, P; Le Lirzin, M | 1 |
Almeyda, J; Levantine, A | 1 |
Mühlberger, F | 1 |
Wolinsky, E | 3 |
Jentgens, H | 1 |
Byrd, RB; Gracey, DR; Kaplan, PD | 1 |
Gomi, J | 1 |
Brazeau, M; Marks, MI; Shapera, RM | 1 |
Berg, G; Kazemi, H; Stottmeier, K; Zack, MB | 1 |
Degtiarev, VP | 1 |
Dye, WE | 1 |
Kreis, B | 1 |
Gartmann, JC | 2 |
Clark, J; Wallace, A | 1 |
Bayliss, CG | 1 |
Hokama, S | 3 |
Kagan, BM; Levin, HS | 1 |
Hejná, A; Hejný, J | 1 |
Grumbach, F | 1 |
Kulikova, MF | 1 |
Bethge, W | 1 |
Steininger, WJ | 1 |
Virchow, C | 1 |
Bialik, IB; Mamolat, AS | 1 |
Lucchesi, M; Mancini, P; Matzeu, M | 1 |
Cohn, ML; Davis, CL | 1 |
Beauchant, G; Brisou, J; Dussouil, P; Rautlin de la Roy Y, DE | 1 |
Bönicke, R; Lippelt, CH | 1 |
Jesiotr, M | 1 |
Lester, W | 2 |
Freerksen, E; Matsumiya, T; Rosenfeld, M | 2 |
Ivaniuta, OM | 1 |
Strauss, I | 1 |
Makarevich, NM; Rudoĭ, NM | 1 |
Bialik, IB | 1 |
Bethge, H | 1 |
Eagle, MC; Goldstein, E; LaCasse, ML | 1 |
Brzaković, N; Goldman, S; Muzikravić, T | 1 |
Eulenberger, J; Mordasini, ER | 1 |
Burgher, LW; Kass, I | 1 |
Horai, Z; Matsumura, K; Shimizu, K; Ueda, Y; Yoneda, H | 1 |
Daynes, G | 1 |
Ehrlich, RM; Lattimer, JK | 1 |
Dantzker, DR; Herndon, JH; Lanoue, AM | 1 |
Evans, P; Reisinger, KS; Rogers, KD; Yost, G | 1 |
Charles, D; MacAulay, M | 1 |
Eule, H | 1 |
Chumachenko, NV; Sokolova, EM; Solov'ev, VN | 1 |
Kass, I | 1 |
Solov'ev, VN; Zueva, VS | 2 |
Zueva, VS | 1 |
Kovalev, GK | 1 |
Pavlov, EP | 1 |
Kanai, K; Kondo, E | 1 |
Ota, Y | 1 |
Ariji, F; Kumano, N; Madokoro, K; Oka, S; Yamaguchi, J | 1 |
Drabkina, RO; Ginzburg, TS | 1 |
Motomura, K; Ogawa, T | 1 |
Kitamoto, O | 2 |
Kanai, K | 1 |
Kaminskaia, GO; Karachunskiĭ, MA; Kolosovskaia, VP | 1 |
Hiramatsu, S; Ogawa, T | 1 |
Hiraki, M; Ogawa, T | 1 |
Allan, GW; Lees, AW; Smith, J; Tyrrell, WF | 1 |
Urbancik, B | 1 |
Dye, WE; Fischer, DA; Lester, W; Moulding, TS | 1 |
Nakamura, K | 1 |
Mikuni, M; Nanba, K; Oishi, M | 1 |
Blalock, FA; Corpe, RF | 1 |
Taniai, S | 1 |
Amelio, M; Bardessono, F; Giorgis, GE; Moschini, MT | 1 |
Cacciatore, R; Hartwig, C; Sanders, WE; Schneider, N; Valdez, H | 1 |
Dambrosi, A; Dambrosi, VM; Gonzalez Montaner, LJ; Manassero, M | 1 |
DeYoung, DR; Roberts, GD; Zimmer, BL | 1 |
Gol'shevskaia, VI; Grishina, TA; Grishina, TD; Karpenko, OL; Safonova, SG | 1 |
Hasegawa, N; Kanazawa, M; Kawashiro, T; Sakamaki, F; Terashima, T | 1 |
Baba, H | 1 |
Gubkina, MF | 1 |
Firsova, VA; Gubkina, MF | 1 |
Amitani, R; Hitomi, S; Kuze, F; Matsumoto, H; Mizuno, H; Suzuki, K; Tanaka, E; Tsuyuguchi, K; Yanagihara, K | 1 |
Chaisuksuwan, R; Pransujarit, V; Punnotok, J; Riantawan, P | 1 |
Okazawa, Y; Sato, N; Tanno, K; Yamazaki, T | 1 |
Miyao, H; Okazawa, Y; Sato, N; Tanno, K; Yamashita, K; Yamazaki, T | 1 |
Naumov, VN; Shaĭkhaev, AIa | 1 |
Dorozhkova, IR; Medvedeva, IM; Popov, SA | 1 |
Ghebremichael, S; Hoffner, SE; Koivula, T; Krüüner, A; Mikelsaar, M; Pehme, L | 1 |
Chen, TP; Chen, YH; Hwang, KP; Lee, YW; Lu, PL; Peng, CF; Tsai, JJ | 1 |
KANAI, K; NAKAJIMA, M; YANAGISAWA, K | 1 |
CATTANEO, C; IPATA, PL | 1 |
GILL, R; HAAPANEN, J; KASS, I; RUSSELL, WF | 1 |
MONTELLA, A; NINNI, A; RAMAGLIA, M | 1 |
GUNELLA, G; MORI, G | 1 |
OHKOSHI, M | 1 |
HEYMER, A | 1 |
CATTANEO, C; DE SIMONI, G | 1 |
KOSAKAI, N | 1 |
TSUCHIMOCHI, T | 1 |
GIRGIS, AS; GLEASON, DM; LATTIMER, JK | 1 |
SHIGEMATSU, T | 1 |
HAGIMA, I; KINOSHITA, Y; MIYAGAWA, T; SEKINE, O; SUZUKI, S; TAKAGI, K; WADA, J; YAMASAKU, F | 1 |
ITO, M; KONDO, K | 1 |
FUJINAGA, R; OKAMOTO, K; YAMAUCHI, H | 2 |
DOROZHKOVA, IR; DYKHNO, MM; KOCHEMASOVA, ZN | 1 |
KANAI, K; MUROHASHI, T; OKAMOTO, S | 1 |
PFUETZE, KH; PYLE, MM | 1 |
NAITO, M | 1 |
SUGIYAMA, K | 1 |
CAPALDO, G; ETTORRE, D; GAGLIARDI, L | 1 |
GRECO, S; MUSSOMELI, A | 1 |
BEK, E | 1 |
BANCALE, A; LUCCHESI, M; ROSSI, P | 1 |
KAKU, R | 1 |
NAGASAWA, J | 1 |
WONG, PC | 1 |
TSUKAMURA, S | 1 |
BROUET, G; MARCHE, J | 1 |
CHARCOSSET, F | 1 |
DUMON, G; GABRIEL, MT; LAUGIER, J; TARANGER, J | 1 |
BERNARD, E; PIERON, R | 1 |
CSERNUS, A; SZENDROEI, Z | 1 |
YAMAMURA, Y | 1 |
KANAI, K; MUROHASHI, T; NAKAMURA, RM | 1 |
SCHWARTZ, WS | 1 |
ACEVEDO, RC; HERRERO, JJ; PILHEU, J; RODRIGUEZ, E | 1 |
CHAVES, AD | 1 |
ALBRECHT, KF | 1 |
TSUKAMURA, M; TSUKAMURA, S | 1 |
KASAI, E; TSUKAMURA, M; TSUKAMURA, S | 1 |
SUTINEN, S; TUOVINEN, PI | 1 |
COMENALE, D; FILLA, E; ROSSI, F | 1 |
HELFMAN, RJ | 1 |
AOJI, I; KAWAGUCHI, M; KINUGASA, S; SANO, Y | 1 |
BINDER, HJ; CONN, HO; ORR, HD | 1 |
BLALOCK, FA; CORPE, RF; GOLDHAMMER, EJ; GROSS, JH | 1 |
JANCIK, E; NOVAK, M | 1 |
SOLOVEV, VN; ZUEVA, VS | 1 |
CORNU, P; FOUQUET, J | 1 |
CHAPMAN, PT; MEDINA, G | 1 |
HORNE, NW | 1 |
GERLOFF, W; KALICH, R; KREBS, A; SCHMIEDEL, A | 1 |
ALLISON, RF; INGLIS, RM; SCHLESS, JM; TOPPERMAN, S; WHITE, EF | 1 |
Kondakova, MN; Pavlova, MV; Sapozhnikova, NV; Skvortsova, LA | 1 |
Krasnov, VA; Ursov, IG | 1 |
Belianin, II; Shmelev, EI | 2 |
Ovsiankina, ES; Panova, LV | 1 |
Chadha, S; Chandrasekar, V; Chauhan, LS; Dave, PV; Dewan, P; Nalini, S; Narayanan, PR; Paramasivan, CN; Parmar, M; Ramachandran, R; Sahu, S; Sanghvi, AS; Wares, F | 1 |
Caminero, JA; Migliori, GB; Sotgiu, G; Zumla, A | 1 |
Robert, J; Veziris, N | 1 |
Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM | 1 |
Connolly, C; Friedland, G; Gandhi, N; Moodley, P; Shah, NS; Sturm, AW; Tayob, N; Zetola, N | 1 |
Barbedo, J; Centis, R; D'Ambrosio, L; Diogo, N; Fernandes, L; Lange, C; Migliori, GB; Raymundo, E; Sotgiu, G; Villar, M | 1 |
de Rijk, P; Fissette, K; Martin, A; Palomino, JC; Ramos, E | 1 |
Eisenberg, N; Govender, K; Hartman, TE; Hatfull, GF; Jacobs, WR; Jain, P; Kriakov, J; Larsen, MH; Makume, M; Moodley, P; O'Donnell, MR; Sturm, AW; Thaler, DS | 1 |
Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
Allen, J; Bassett, IV; Chetty, S; Freedberg, KA; Giddy, J; Hom, JK; Losina, E; Mazibuko, M; Walensky, RP; Wang, B | 1 |
Lu, J; Pang, Y; Song, Y; Wang, S; Wang, Y; Zhao, Y | 1 |
Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S | 1 |
Alcántara, F; Atwood, SS; Becerra, MC; Bonilla, CA; Mitnick, CD; Seung, KJ | 1 |
Chen, Y; Li, GL; Liu, HC; Liu, ZG; Sun, Q; Wan, KL; Wu, XC; Xia, Q; Zhao, LL; Zhao, XQ | 1 |
Chiang, CY; Madan, J; Meredith, SK; Nunn, AJ; Phillips, PP; Rusen, ID; Squire, SB; Torrea, G; Van Deun, A | 1 |
Choi, SB; Jo, KW; Jung, H; Kang, MR; Lee, YS; Shim, TS | 1 |
Abena Foe, JL; Aït-Khaled, N; Kuaban, C; Noeske, J; Rieder, HL; Trébucq, A | 1 |
Ardizzoni, E; Aspindzelashvili, R; Bastard, M; de Jong, BC; Goginashvili, L; Kotrikadze, T; Mulders, W; Pangtey, H; Rigouts, L; Varaine, F | 1 |
Sibbald, B | 1 |
Allnutt, JC; Bacon, J; Bottley, G; Doris, KS; Hatch, KA; Hendon-Dunn, CL; Marriott, AA; Marsh, PD; Taylor, SC; Thomas, SR; Watson, RJ | 1 |
Deng, YT; Huang, ZK; Li, JM; Luo, Q; Qing, C; Xiong, GL | 1 |
Alling, T; Bailey, MA; Casey, A; Early, JV; Files, M; Gonzalez Valcarcel, IC; Martinez-Grau, MA; Ollinger, J; Ovechkina, Y; Parish, T; Vieth, M | 1 |
Chen, ST; Huang, HR; Jiang, GL; Ma, YF; Wang, GR; Yu, X | 1 |
Catanzaro, A; Catanzaro, D; Crudu, V; Garfein, RS; Georghiou, SB; Rodrigues, C; Rodwell, TC; Seifert, M; Valafar, F; Victor, TC | 1 |
Dixit, P; Jain, A; Jaiswal, I; Singh, M; Singh, P; Singhal, P | 1 |
Catanzaro, A; Catanzaro, D; Crudu, V; Garfein, RS; Georghiou, SB; Jackson, RL; Lin, SY; Rodrigues, C; Rodwell, TC; Seifert, M; Victor, TC | 1 |
Aldaba, JG; Ama, CG; Geraldino, XD; Lopez, AL; Salonga, AM; Sarol, JN; Sylim, PG | 1 |
Alland, D; Barry, CE; Chakravorty, S; Gall, A; Gao, Q; Glass, J; Jones, M; Kwiatkawoski, R; Lee, JS; Liu, X; Lokhov, S; Lund, K; Persing, D; Roh, SS; Rowneki, M; Ruan, X; Shen, Q; Shenai, S; Simmons, AM; Smith, LE; Via, LE; Viazovkina, E; Xu, P; Yuan, X; Zhang, G; Zhu, HZ | 1 |
Aono, A; Chikamatsu, K; Igarashi, Y; Mitarai, S; Takaki, A; Yamada, H; Yi, L | 1 |
Antiabong, JF; Lekalakala, RM; Malinga, LA; Maningi, NE; Mbelle, NM | 1 |
Cao, P; Doan, TN; Emeto, TI; McBryde, ES; McCaw, JM | 1 |
Amukoye, E; Nonoh, J; Nyamache, AK; Ogari, CO | 1 |
Bang, H; Barry, CE; Dartois, V; Eum, S; Fox, WS; Gupta, SV; Lee, M; Savic, RM; Shim, T; Strydom, N; Via, LE; Zimmerman, M | 1 |
Gardezi, AH; Hussain, A; Ikram, A; Khadim, MT; Satti, L; Zaman, G | 1 |
Jafari, R; Moghim, S; Nasr Esfahani, B; Safari, M; Salehi, M | 1 |
Achar, J; Azamat, I; Bayram, H; Gil, H; Gomez, D; Margaryan, H; Nazirov, P; Parpieva, N; Singh, J; Zayniddin, S; Ziba, B | 1 |
Ji, Y; Li, Z; Liu, Q; Martinez, L; Qiu, B; Song, H; Wang, J; Yang, D | 1 |
Barr, DA; Davies, G; Koch, A; Lalloo, DG; Mason, M; Meintjes, G; Mizrahi, V; Omollo, C; Warner, DF; Wilkinson, RJ | 1 |
Bhalla, M; Ciobanu, N; Conradie, F; Crudu, V; David, A; Denkinger, CM; Georghiou, SB; Kazi, M; Myneedu, VP; Penn-Nicholson, A; Rodrigues, C; Ruhwald, M; Schumacher, SG; Scott, L | 1 |
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
Guo, Y; Huang, C; Sha, W; Tan, G; Wu, X; Yang, J; Yu, F | 1 |
Alarcón, MJ; Coronel, J; Cotrina, VV; Moore, DAJ; Puyén, ZM; Santos-Lázaro, D; Vigo, AN | 1 |
Adhikary, A; Biswal, S; Chatterjee, D; Ghosh, AS | 1 |
Catanzaro, A; Catanzaro, DG; Chiles, P; Ciobanu, N; Codreanu, A; Colman, RE; Cooney, CG; Crudu, V; Hillery, N; Holmberg, RC; Kukhtin, AV; Linger, Y; Norville, R; Rodwell, TC; Seifert, M; Syed, RR | 1 |
Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A | 1 |
17 review(s) available for kanamycin a and isoniazid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fluoroquinolone-isatin hybrids and their biological activities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Fluoroquinolones; Humans; Isatin; Structure-Activity Relationship | 2019 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Drug-resistance in
Topics: | 2019 |
Treatment of tuberculosis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Child; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Time Factors; Tuberculosis; Viomycin | 1975 |
Chromatographic analysis of antituberculosis drugs in biological samples.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Chromatography; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Kinetics; Monitoring, Physiologic; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Viomycin | 1985 |
Contact dermatitis to antituberculosis drugs.
Topics: Aminosalicylic Acid; Antitubercular Agents; Cross Reactions; Dermatitis, Contact; Desensitization, Immunologic; Ethambutol; Humans; Isoniazid; Kanamycin; Rifampin; Skin Tests; Streptomycin | 1986 |
Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Cycloserine; Drug Eruptions; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Pyrazinamide; Rifampin; Skin; Stomatitis; Streptomycin; Thioacetazone; Viomycin | 1972 |
[Chemotherapeutic studies on advanced tuberculosis in mice].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mice; Models, Biological; Phenazines; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1965 |
Genitourinary tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Child; Child, Preschool; Cycloserine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethionamide; Female; Follow-Up Studies; Humans; Hypertension, Renal; Isoniazid; Kanamycin; Male; Nephrectomy; Pyridoxine; Radiography; Rifampin; Tuberculosis, Renal; Tuberculosis, Urogenital; United States | 1974 |
Use of antibiotics in obstetric practice.
Topics: Anti-Bacterial Agents; Biological Transport; Blood Chemical Analysis; Cell Membrane Permeability; Cephaloridine; Chloramphenicol; Colistin; Extraembryonic Membranes; Female; Fetal Diseases; Fetus; Humans; Isoniazid; Kanamycin; Maternal-Fetal Exchange; Penicillins; Placenta; Pregnancy; Pregnancy Complications, Infectious; Protein Binding; Rupture; Streptomycin; Tetracycline; Umbilical Cord | 1970 |
[Current status of chemotherapy of pulmonary tuberculosis and its further prospectives].
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Hemorrhagic Disorders; Humans; Isoniazid; Kanamycin; Phenylthiourea; Purpura, Thrombocytopenic; Pyrazines; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1971 |
Pulmonary infection due to Mycobacterium xenopi.
Topics: Bacterial Typing Techniques; Clarithromycin; Cycloserine; DNA Probes; Drug Resistance, Microbial; Gastrectomy; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium Infections; Respiratory Tract Infections; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
[COMPLICATIONS OF A METABOLIC AND ENDOCRINE NATURE PRODUCED BY ANTIBACILLARY CHEMOTHERAPY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Avitaminosis; Cycloserine; Endocrinology; Ethionamide; Isoniazid; Kanamycin; Metabolic Diseases; Niacin; Niacinamide; Pyrazinamide; Streptomycin; Sulfones; Thiosemicarbazones; Toxicology; Viomycin; Vitamin B 6 Deficiency | 1964 |
[UROGENITAL TUBERCULOSIS: PATHOGENESIS, DIAGNOSIS AND THERAPY. SURVEY OF THE MOST IMPORTANT PUBLICATIONS OF THE LAST YEARS].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Phenylthiourea; Pyrazinamide; Serologic Tests; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Urogenital; Urine | 1964 |
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Ofloxacin; Pyrazinamide; Tuberculosis | 2010 |
[Anti-tuberculosis drug resistance and therapeutic dead end].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Capreomycin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Injections; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Tuberculosis | 2010 |
3 trial(s) available for kanamycin a and isoniazid
Article | Year |
---|---|
Ethambutol in re-treatment of pulmonary tuberculosis.
Topics: Adult; Anti-Bacterial Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Radiography; Sputum; Tuberculosis, Pulmonary; United States; United States Public Health Service; Viomycin; Vision, Ocular | 1968 |
Drug-induced heart failure in advanced pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Heart Failure; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
Topics: Antitubercular Agents; Bangladesh; Clinical Protocols; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Moxifloxacin; Prothionamide; Pyrazinamide; Research Design; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
256 other study(ies) available for kanamycin a and isoniazid
Article | Year |
---|---|
Synthesis and antibacterial activity of 2,2'-dithiobis(benzamide) derivatives against Mycobacterium species.
Topics: Animals; Benzamides; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Mice; Mycobacterium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Structure-Activity Relationship; Sulfides | 1985 |
Norditerpenoids and diterpenoids from Salvia multicaulis with antituberculous activity.
Topics: Antitubercular Agents; Chromatography, Liquid; Diterpenes; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plants, Medicinal; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Turkey | 1997 |
Antituberculous activity of some aryl semicarbazone derivatives.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Semicarbazones; Structure-Activity Relationship | 2004 |
Antitubercular sesterterpenes from the Thai sponge Brachiaster sp.
Topics: Animals; Antineoplastic Agents; Antitubercular Agents; Drug Screening Assays, Antitumor; Molecular Structure; Porifera; Sesterterpenes; Terpenes; Thailand; Tumor Cells, Cultured | 2004 |
Identification of heteroarylenamines as a new class of antituberculosis lead molecules.
Topics: Amines; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2005 |
Integerrimides A and B, cyclic heptapeptides from the latex of Jatropha integerrima.
Topics: Animals; Antineoplastic Agents, Phytogenic; Candida albicans; Chickens; Drug Screening Assays, Antitumor; Herpesvirus 1, Human; Humans; Jatropha; Latex; Molecular Structure; Neurites; Peptides, Cyclic; Plants, Medicinal; Plasmodium falciparum; Spinal Cord; Thailand | 2006 |
Antimalarial and antituberculous poly-O-acylated jatrophane diterpenoids from Pedilanthus tithymaloides.
Topics: Amphotericin B; Antimalarials; Antitubercular Agents; Candida albicans; Diterpenes; Drug Resistance, Multiple, Bacterial; Euphorbiaceae; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Oxygen; Plants, Medicinal; Thailand | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Biomimetic transformation and biological activities of Globiferin, a terpenoid benzoquinone from Cordia globifera.
Topics: Antifungal Agents; Antimalarials; Antitubercular Agents; Benzoquinones; Biotransformation; Candida albicans; Cordia; Drug Resistance, Multiple; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Roots; Plants, Medicinal; Plasmodium falciparum; Terpenes; Thailand | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents.
Topics: Alkanes; Animals; Antitubercular Agents; Cattle; Cell Line; Cell Survival; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Prenylation | 2009 |
Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Carbohydrates; Chemistry, Pharmaceutical; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfides | 2009 |
Diterpenes, sesquiterpenes, and a sesquiterpene-coumarin conjugate from Jatropha integerrima.
Topics: Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Diterpenes; Drug Resistance, Microbial; Drug Screening Assays, Antitumor; Jatropha; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Plant Roots; Plants, Medicinal; Plasmodium falciparum; Sesquiterpenes; Thailand | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Topics: Anti-Bacterial Agents; Erythromycin; Luminescent Proteins; Microbial Sensitivity Tests; Models, Genetic; Mycobacterium ulcerans; Reserpine; Tetracycline | 2010 |
Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.
Topics: Antitubercular Agents; Curcuma; Curcumin; Humans; Isoxazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2010 |
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The design, synthesis, in silico ADME profiling, antiplasmodial and antimycobacterial evaluation of new arylamino quinoline derivatives.
Topics: Aminoquinolines; Antiprotozoal Agents; Antitubercular Agents; Biological Assay; Blood-Brain Barrier; Computer Simulation; Drug Design; Erythrocytes; Humans; Inhibitory Concentration 50; Mefloquine; Microbial Sensitivity Tests; Models, Biological; Mycobacterium tuberculosis; Plasmodium falciparum; Quinine; Structure-Activity Relationship; Tetrazoles | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Chlorinated coumarins from the polypore mushroom Fomitopsis officinalis and their activity against Mycobacterium tuberculosis.
Topics: Agaricales; Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Cytotoxins; Hydrocarbons, Chlorinated; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Vero Cells | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Azabicyclo Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship; Tissue Distribution; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2015 |
New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold.
Topics: Antitubercular Agents; Bacterial Proteins; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Oxidoreductases; Pyrans; Structure-Activity Relationship; Tuberculosis | 2016 |
Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Oxadiazoles; Pyridines; Structure-Activity Relationship; Tuberculosis | 2016 |
Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Combinatorial Chemistry Techniques; Green Chemistry Technology; Humans; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazolidines; Tuberculosis | 2016 |
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacteria; Cell Line; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Fungi; Humans; Latent Tuberculosis; Microbial Sensitivity Tests; Microsomes; Mutagens; Mycobacterium tuberculosis; Oxazoles; Primary Cell Culture; Rifampin; Structure-Activity Relationship; Thiadiazoles | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Design; Humans; Mycobacterium tuberculosis; Oxadiazoles | 2016 |
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies.
Topics: Administration, Oral; Animals; Antitubercular Agents; Blood Proteins; Drug Stability; High-Throughput Screening Assays; Humans; Male; Mice, Inbred C57BL; Microsomes, Liver; Mycobacterium tuberculosis; Proteomics; Pyrimidines; Small Molecule Libraries; Structure-Activity Relationship | 2017 |
Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Benzyl Compounds; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyridines; Quaternary Ammonium Compounds; Rats; Saccharomyces cerevisiae; Salts; Structure-Activity Relationship; Trypanosoma brucei rhodesiense | 2018 |
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
Topics: Amides; Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2019 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
Topics: Antitubercular Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Polyketide Synthases; Quinolones; Structure-Activity Relationship | 2021 |
Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives.
Topics: Animals; Anti-Bacterial Agents; Hydrazines; Hydroxamic Acids; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Structure-Activity Relationship | 2022 |
Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent.
Topics: Animals; Antitubercular Agents; Long QT Syndrome; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2022 |
Synthesis, biological evaluation and computational studies of pyrazole derivatives as
Topics: | 2022 |
Side effects of drugs used to treat tuberculosis.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Capreomycin; Chemical and Drug Induced Liver Injury; Cycloserine; Deafness; Drug Hypersensitivity; Ethambutol; Ethionamide; Gastrointestinal Diseases; Goiter; Humans; Isoniazid; Kanamycin; Liver; Mental Disorders; Mice; Nervous System Diseases; Pyrazinamide; Rifampin; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1975 |
Investigation into the relationship of M ulcerans to M. buruli and other mycobacteria.
Topics: Capreomycin; Culture Media; Drug Resistance, Microbial; Ethambutol; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; Streptomycin; Temperature; Thiosemicarbazones; Viomycin | 1975 |
Identification and drug sensitivity of tubercle bacilli from Addis Ababa, Ethiopia.
Topics: Aminosalicylic Acid; Ethiopia; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thiosemicarbazones | 1978 |
[The use of mycobacteria in the estimation of the concentration of antibiotics, antimycotics and antituberculotics (author's transl)].
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Bacitracin; Drug Resistance, Microbial; Ethambutol; Ethionamide; Gentamicins; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Neomycin; Rifampin; Streptomycin; Time Factors | 1978 |
[Ultrastructural change in Mycobacterium tuberculosis under the influence of antibacterial preparations (a review of the literature)].
Topics: Antitubercular Agents; Cell Nucleus; Cell Wall; Cycloserine; Cytoplasm; Ethambutol; Intracellular Membranes; Isoniazid; Kanamycin; Microscopy, Electron; Microscopy, Electron, Scanning; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1979 |
Analysis of metabolic changes in revertants of antibiotic-resistant micobacteria.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Ethambutol; Extrachromosomal Inheritance; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Neomycin; Rifampin; Streptomycin; Viomycin | 1975 |
[Iron metabolism in tuberculosis during complex treatment].
Topics: Adolescent; Adult; Chronic Disease; Drug Therapy, Combination; Ethionamide; Female; Humans; Iron; Isoniazid; Kanamycin; Male; Middle Aged; Tuberculosis, Pulmonary | 1978 |
[Successfully operated case of posterior fossa tuberculoma in childhood (author's transl)].
Topics: Aminosalicylic Acids; Child, Preschool; Cranial Fossa, Posterior; Humans; Isoniazid; Kanamycin; Male; Radiography; Skull; Tuberculoma | 1976 |
Lesions of bone in disseminated infection due to the mycobacterium avium-intracellulare group. Report of a case.
Topics: Adolescent; Bone Diseases; Bone Neoplasms; Child; Diagnosis, Differential; Ethambutol; Hodgkin Disease; Humans; Isoniazid; Kanamycin; Male; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Radiography; Rifampin; Time Factors | 1975 |
Ethanol-antibiotic interactions at hepatic level.
Topics: Acute Disease; Alcoholic Intoxication; Animals; Anti-Bacterial Agents; Chronic Disease; Drug Interactions; Ethanol; Gentamicins; Humans; Isoniazid; Kanamycin; Liver; Male; Rats; Rifampin; Streptomycin; Sulfobromophthalein | 1975 |
Isolation and characterization of isoniazid-resistant mutants of Mycobacterium smegmatis and M. aurum.
Topics: Catalase; Chromatography, Thin Layer; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; In Vitro Techniques; Isoniazid; Kanamycin; Mutagenesis; Mycobacterium; Mycolic Acids; Peroxidases; Rifampin; Streptomycin | 1992 |
Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
From the Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons, correctional system--New York, 1991.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; HIV Seropositivity; Humans; Immunocompromised Host; Isoniazid; Kanamycin; Mycobacterium tuberculosis; New York; Prisons; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis | 1992 |
[Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
Topics: Adult; Aged; Drug Therapy, Combination; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1991 |
MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Culture Media; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1988 |
Mycobacterium simiae as a cause of intra-abdominal disease: a case report.
Topics: Abdomen; Adult; Ascitic Fluid; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Pyrazinamide; Rifampin | 1989 |
Improvement of drg-sensitivity tests on tubercle bacilli.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Thioacetazone; Viomycin | 1970 |
The first clinical experiences with ethambutol in chronic pulmonary tuberculosis and basilar meningitis.
Topics: Adult; Aminosalicylic Acids; Capreomycin; Chronic Disease; Cycloserine; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Meningitis; Middle Aged; Pyrazinamide; Radiography; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1970 |
Clinical experience with ethambutol.
Topics: Aminosalicylic Acids; Blood Chemical Analysis; Capreomycin; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Gentamicins; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1970 |
[Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Dihydrostreptomycin Sulfate; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary | 1971 |
Trends in the prevalence of primary drug resistance in pulmonary tuberculosis in France from 1962 to 1970: a national survey.
Topics: Adolescent; Adult; Africa, Northern; Age Factors; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Ethnicity; Female; France; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary; Viomycin | 1972 |
[Allergy to antitubercular agents; with special reference to new drugs].
Topics: Adult; Aged; Agranulocytosis; Anaphylaxis; Antitubercular Agents; Capreomycin; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Thrombocytopenia; Viomycin | 1973 |
Nontuberculous mycobacterial infections of man.
Topics: Capreomycin; Child; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Lung Diseases; Lymphadenitis; Mycobacterium; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious; Sputum; Streptomycin | 1974 |
[Drug therapy of tuberculosis].
Topics: Amides; Aminosalicylic Acids; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Isonicotinic Acids; Kanamycin; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Tetracycline; Thiosemicarbazones; Tuberculosis; Viomycin | 1974 |
Treatment of pulmonary tuberculosis.
Topics: Capreomycin; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cycloserine; Depression; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Hospitalization; Humans; Isoniazid; Kanamycin; Kidney Diseases; Optic Neuritis; Patient Education as Topic; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
Comparative studies on various antituberculosis chemotherapies--from the results of the Tuberculosis Research Committee (Ryoken).
Topics: Aminosalicylic Acids; Antitubercular Agents; Ethambutol; Humans; Isoniazid; Kanamycin; Radiography; Streptomycin; Thioacetazone; Tuberculosis, Pulmonary | 1966 |
Drugs for tuberculosis.
Topics: Aminosalicylic Acids; Costs and Cost Analysis; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Thioacetazone; Tuberculosis; Viomycin | 1968 |
Pediatric antimicrobial therapy. II.
Topics: Bacteria; Colistin; Drug Therapy; Erythromycin; Escherichia coli; Ethambutol; Gentamicins; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Pediatrics | 1973 |
The effect of radiation on microbiologic characteristics of M tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cell Survival; Chromosomes, Bacterial; Cycloserine; Dose-Response Relationship, Radiation; Drug Resistance, Microbial; Ethambutol; Ethionamide; Freezing; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Preservation, Biological; Pyrazinamide; Radiation Genetics; Rifampin; Streptomycin | 1974 |
[Results of outpatient treatment of tuberculous patients in a rural area of the Moldavian SSR].
Topics: Adolescent; Adult; Ambulatory Care; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Moldova; Pyrazinamide; Rural Health; Streptomycin; Thiosemicarbazones; Tuberculosis | 1974 |
Bacteriology of tuberculosis with special reference to kanamycin and related drugs.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Tuberculosis; Viomycin | 1966 |
Kanamycin: its therapeutic record in pulmonary tuberculosis in France and other European countries.
Topics: Adult; Aged; Aminosalicylic Acids; Animals; Antitubercular Agents; Ethionamide; Europe; France; Guinea Pigs; Humans; Isoniazid; Kanamycin; Mice; Middle Aged; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1966 |
[Therapy of pulmonary tuberculosis in its current aspects].
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Isoniazid; Kanamycin; Phenylthiourea; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1965 |
The susceptibility of mycobacteria to rifamide and rifampicin.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Viomycin | 1967 |
Treatment of pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1967 |
Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Isoniazid; Kanamycin; Mice; Phenylthiourea; Streptomycin; Tuberculosis; Viomycin | 1967 |
Antimicrobial agents: pediatric dosage, routes of administration and preparation procedures for parenteral therapy.
Topics: Amphotericin B; Anti-Infective Agents; Bacitracin; Cephalothin; Chloramphenicol; Colistin; Erythromycin; Humans; Isoniazid; Kanamycin; Lincomycin; Neomycin; Nitrofurantoin; Novobiocin; Oleandomycin; Polymyxins; Streptomycin; Sulfadiazine; Sulfisoxazole; Tetracycline; Viomycin | 1968 |
[The drug treatment of renal tuberculosis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Isoniazid; Kanamycin; Phenylthiourea; Pyrazinamide; Streptomycin; Tuberculosis, Renal; Ureteral Obstruction; Viomycin | 1967 |
[The secondary sensitivity of mycobacteria].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Streptomycin; Viomycin | 1967 |
[Distribution of the range of natural sensitivity to antitubercular preparations in cultures of strains of mycobacterum BCG].
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Isoniazid; Kanamycin; Mycobacterium bovis; Streptomycin; Viomycin | 1968 |
[Frequency of side-effects of tuberulostatics and its relation to the applied combination].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Drug Synergism; Drug Tolerance; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Sex Factors; Streptomycin; Time Factors; Tuberculosis, Pulmonary; Viomycin | 1968 |
Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
Topics: Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Thiosemicarbazones; Tuberculosis, Pulmonary; United States; United States Public Health Service; Viomycin | 1968 |
[Actual tuberculosis therapy. An attempt to simplify and to determine a schedule of tuberculosis chemotherapy].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Oxytetracycline; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1969 |
[Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Kanamycin; Middle Aged; Tuberculosis, Pulmonary; Viomycin | 1969 |
[Drug sensitivity of the so-called atypical mycobacteria].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Morpholines; Mycobacterium; Pyrazinamide; Pyrazines; Rifampin; Streptomycin; Viomycin | 1968 |
Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs.
Topics: Aminosalicylic Acids; Animals; Anti-Bacterial Agents; Catalase; Culture Media; Drug Resistance, Microbial; Ethambutol; Ethionamide; Guinea Pigs; Isoniazid; Kanamycin; Lung; Mycobacterium tuberculosis; Spleen; Streptomycin; Viomycin | 1970 |
[Primary and secondary resistance in 257 cases of pulmonary tuberculosis from 1964 to 1966 at the Pneumology Service in Poitiers].
Topics: Aminosalicylic Acids; Antitubercular Agents; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1967 |
[The activity of nicotinic acid hydroxylase and pyrocatechase in chemosensitive mycobacteria and their chemoresistant variants].
Topics: Catechols; Chemical Phenomena; Chemistry; Colorimetry; Culture Media; Drug Resistance, Microbial; Genetic Variation; Genetics, Microbial; Isoniazid; Kanamycin; Mixed Function Oxygenases; Mycobacterium; Nicotinic Acids; Oxygenases; Streptomycin; Viomycin | 1968 |
Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis.
Topics: Chronic Disease; Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Kanamycin; Pyrazinamide; Tuberculosis, Pulmonary; Viomycin | 1969 |
Chemotherapy of tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1970 |
[Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice].
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Ethambutol; Ethionamide; Injections, Intravenous; Isoniazid; Kanamycin; Mice; Mycobacterium tuberculosis; Phenylthiourea; Streptomycin; Tuberculosis; Viomycin | 1970 |
[Intravenous chemotherapy of pulmonary tuberculosis].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Ethionamide; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Middle Aged; Streptomycin; Tuberculoma; Tuberculosis, Lymph Node; Tuberculosis, Meningeal; Tuberculosis, Pulmonary; Viomycin | 1971 |
[Tuberculostatic tolerance of a tuberculous kidney].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Tolerance; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Streptomycin; Tuberculosis, Renal; Viomycin | 1969 |
[Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Depression, Chemical; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
[Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
Topics: Adolescent; Adult; Albuminuria; Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cycloserine; Depression, Chemical; Drug Resistance, Microbial; Eosinophilia; Ethionamide; Headache; Hearing Disorders; Hematuria; Humans; Isoniazid; Kanamycin; Lung Diseases; Middle Aged; Mycobacterium tuberculosis; Pruritus; Pyrazinamide; Respiratory Therapy; Tachycardia; Thiosemicarbazones; Time Factors; Tinnitus; Tuberculosis, Pulmonary; Vertigo; Vestibule, Labyrinth; Viomycin | 1971 |
Treatment of drug-resistant tuberculosis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Eruptions; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Humans; Hypothyroidism; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1971 |
[Advances and principles in tuberculostatic therapy].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Phenylthiourea; Pyrazinamide; Rifampin; Streptomycin; Thiosemicarbazones; Tuberculosis; Viomycin | 1971 |
In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
Topics: Antitubercular Agents; Bacteriological Techniques; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Viomycin | 1971 |
Clinical and bacteriological results with Myambutol.
Topics: Adult; Chronic Disease; Cycloserine; Drug Combinations; Drug Resistance; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Lung; Male; Phenylthiourea; Radiography; Time Factors; Tuberculosis, Pulmonary; Viomycin | 1970 |
[Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Topics: Adult; Aged; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Viomycin | 1971 |
[Tuberculostatics. General adverse effects].
Topics: Adult; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Neomycin; Oxytetracycline; Rifampin; Streptomycin; Thiosemicarbazones; Viomycin | 1972 |
Treatment of tuberculosis today in Nebraska.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Hypersensitivity; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Pyridoxine; Rifampin; Sputum; Streptomycin; Tuberculosis; Viomycin | 1973 |
New antituberculosis drugs and concepts of prophylaxis.
Topics: Aminosalicylic Acids; Antitubercular Agents; Arthritis; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Hypersensitivity; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Liver; Lupus Vulgaris; Male; Middle Aged; Pyrazinamide; Rifampin; Streptomycin; Tuberculin Test; Tuberculosis; Viomycin | 1974 |
[Induction of Mycobacterium infection by introduction of the organisms into the lung through an intratracheal vinyl tube].
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Dust; Ethambutol; Guinea Pigs; Intubation, Intratracheal; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Silicon Dioxide; Tuberculosis, Pulmonary | 1972 |
[Usefulness of rifampicin for pulmonary resection of drug-resistant pulmonary tuberculosis--report of the 13th series study. C].
Topics: Adolescent; Adult; Aged; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pneumonectomy; Postoperative Complications; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1973 |
Mycobacterium fortuitum infections involving the extremities. Report of three cases.
Topics: Adult; Amputation, Surgical; Amputation, Traumatic; Arm Injuries; Drainage; Drug Resistance, Microbial; Ethionamide; Humans; Isoniazid; Kanamycin; Leg Injuries; Male; Military Medicine; Mycobacterium Infections; Surgical Wound Infection; Tetracycline; Tuberculin Test; United States; Vietnam; Wound Infection | 1972 |
Congenital tuberculosis: report of a case.
Topics: Adult; Ampicillin; Ethambutol; Female; Fever; Humans; Infant; Infant, Newborn; Isoniazid; Kanamycin; Pregnancy; Streptomycin; Tuberculosis, Female Genital; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1974 |
[Effect of kanamycin and isoniazid on the sensitivity of Mycobacterium tuberculosis to the defensive factors of the macroorganism].
Topics: Animals; Drug Resistance, Microbial; Isoniazid; Kanamycin; Mice; Mycobacterium tuberculosis; Tuberculosis, Avian | 1965 |
Kanamycin in the therapy of pulmonary tuberculosis in the United States.
Topics: Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Phenylthiourea; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary; United States; Vestibulocochlear Nerve | 1966 |
[Sensitivity to chemotherapeutic agents of Mycobacterium tuberculosis after brief stay in the organism of albino mice].
Topics: Animals; Culture Media; Cycloserine; Drug Resistance, Microbial; Isoniazid; Kanamycin; Liver; Mice; Mycobacterium tuberculosis; Trypsin | 1968 |
[Effects of trypsin and the products of trypsinization of the liver, lung and spleen on the sensitivity of Mycobacterium tuberculosis to chemotherapeutic substances].
Topics: Culture Techniques; Cycloserine; Drug Resistance, Microbial; Isoniazid; Kanamycin; Liver; Lung; Methods; Mycobacterium tuberculosis; Spleen; Trypsin | 1967 |
[Determination of drug sensitivity of Mycobacterium tuberculosis by means of potassium tellurite].
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethionamide; Humans; Indicators and Reagents; Isoniazid; Kanamycin; Methods; Mycobacterium tuberculosis; Potassium; Streptomycin; Tellurium; Tuberculosis, Pulmonary | 1969 |
[Effect of acridine compounds on the development of drug resistance to antitubercular agents of Mycobacterium of avian type].
Topics: Acridines; Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Quinacrine; Streptomycin; Tuberculosis | 1969 |
[Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice].
Topics: Animals; Cycloserine; Drug Resistance, Microbial; Endopeptidases; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mice; Mycobacterium tuberculosis; Streptomycin; Sulfamethoxypyridazine; Tuberculosis | 1970 |
[Factors affecting the activity of streptomycin, kanamycin and isoniazid in relation to intracellular Mycobacterium tuberculosis].
Topics: Animals; Culture Techniques; Isoniazid; Kanamycin; Mice; Mycobacterium tuberculosis; Phagocytosis; Spleen; Streptomycin | 1970 |
Limits in tuberculosis chemotherapy as revealed by experimental study in mice.
Topics: Animals; BCG Vaccine; Drug Resistance, Microbial; Isoniazid; Kanamycin; Lung; Male; Mice; Mycobacterium tuberculosis; Spleen; Streptomycin; Tuberculosis | 1971 |
[Studies on the effects of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). II. Studies in vivo].
Topics: Animals; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred Strains; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis | 1971 |
Mode of action of antituberculous agents and ultrastructure of mycobacteria.
Topics: Animals; Antitubercular Agents; Cycloserine; Ethambutol; Isoniazid; Kanamycin; Mice; Microscopy, Electron; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 1971 |
[Efficiency of interrupted therapy of tuberculosis (experimental study)].
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Methods; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1972 |
[Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
Topics: Adult; Aminosalicylic Acids; Cycloserine; Ethionamide; Evaluation Studies as Topic; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Streptomycin; Tuberculosis, Pulmonary | 1972 |
[Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis].
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Isoniazid; Kanamycin; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Spleen; Streptomycin; Sulfonamides; Tuberculosis | 1971 |
Kanamycin: its therapeutic record in pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Hearing Disorders; Humans; Isoniazid; Japan; Kanamycin; Pneumonectomy; Radiography; Streptomycin; Tuberculosis, Pulmonary | 1966 |
Experimental studies on host-parasite equilibrium in tuberculous infection, in relation to vaccination and chemotherapy.
Topics: Animals; BCG Vaccine; Guinea Pigs; Isoniazid; Kanamycin; Male; Mice; Mycobacterium; Streptomycin; Tuberculosis | 1966 |
Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
Topics: Aminosalicylic Acids; Animals; Antitubercular Agents; Cycloserine; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Male; Mice; Mycobacterium; Pyrazinamide; Streptomycin; Tuberculosis | 1967 |
Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Topics: Adolescent; Adult; Aminoisobutyric Acids; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Phenylthiourea; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1967 |
[Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
Topics: Adult; Antitubercular Agents; Cycloserine; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Liver; Liver Function Tests; Male; Middle Aged; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1969 |
Studies on atypical mycobacteria. 8. Chemotherapy and auto-senitized vaccine therapy aganist experimentally atypical mycobacteriosis of mice--experiments on Moristrain infection in mice.
Topics: Aminosalicylic Acids; Animals; Anti-Bacterial Agents; Antitubercular Agents; Bacterial Vaccines; Cycloserine; Ethambutol; Injections, Subcutaneous; Isoniazid; Kanamycin; Lung; Male; Mice; Mycobacterium Infections; Spleen; Streptomycin | 1969 |
Studies on atypical mycobacteria. IX. Chemotherapy gainst exprimentally atypical mycobacteriosis of mice--experiments on Morita strain infection in mice.
Topics: Aminosalicylic Acids; Animals; Anti-Bacterial Agents; Cycloserine; Ethambutol; Ethionamide; Injections, Subcutaneous; Isoniazid; Kanamycin; Lung; Male; Mice; Mycobacterium Infections; Spleen; Streptomycin; Sulfonamides | 1969 |
Ethambutol in the retreatment of chronic pulmonary tuberculosis.
Topics: Aminosalicylic Acids; Chronic Disease; Cycloserine; Depression, Chemical; Drug Synergism; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Pyrazinamide; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1970 |
Clinical experience with Myambutol in the treatment of polyresistant chronic tuberculosis.
Topics: Adult; Cycloserine; Drug Combinations; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Phenylthiourea; Pyrazinamide; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 1970 |
Re-treatment of patients with isoniazid-resistant tuberculosis. Analysis and follow-up of 146 cases.
Topics: Adult; Antitubercular Agents; Cycloserine; Drug Resistance, Microbial; Drug Synergism; Ethionamide; Follow-Up Studies; Humans; Isoniazid; Kanamycin; Pyrazinamide | 1968 |
[Psychiatric and neurological symptoms caused by cycloserine poisoning].
Topics: Adolescent; Adult; Cycloserine; Electroencephalography; Ethionamide; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Neurologic Manifestations; Psychoses, Substance-Induced; Sulfonamides; Tuberculosis, Pulmonary | 1968 |
Effects of ethambutol on tuberculous diseases of the eye.
Topics: Adolescent; Adult; Aged; Child, Preschool; Ethambutol; Female; Gastrointestinal Diseases; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Optic Neuritis; Streptomycin; Tuberculosis, Ocular | 1969 |
Retreatment of drug resistant tuberculosis at Battey State Hospital.
Topics: Adolescent; Adult; Aged; Cycloserine; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Middle Aged; Tuberculosis, Pulmonary | 1965 |
[Studies on the treatment of experimental chronic tuberculosis with steroid hormone as a stimulation therapy and the distribution of 14C-labeled isoniazid in the tuberculous mice].
Topics: Animals; Carbon Isotopes; Chronic Disease; Ethionamide; Female; Isoniazid; Kanamycin; Lung; Mice; Prednisolone; Tuberculosis, Pulmonary | 1967 |
[Changes in the primary resistance to Mycobacterium tuberculosis in Piedmont 1965-1979].
Topics: Antibiotics, Antitubercular; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Italy; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1981 |
Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.
Topics: Amikacin; Animals; Female; Isoniazid; Kanamycin; Mice; Mycobacterium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Streptomycin; Tuberculosis, Pulmonary | 1982 |
Adverse effects of antituberculosis drugs causing changes in treatment.
Topics: Antitubercular Agents; Humans; Isoniazid; Kanamycin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1982 |
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
Topics: Antitubercular Agents; Drug Synergism; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Rifampin; Streptomycin | 1982 |
[Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Pulmonary | 1995 |
[Studies on the problems of resistance to antituberculous drugs. II--2. Clinically significant critical concentration of streptomycin, isoniazid, kanamycin and ethambutol].
Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin | 1994 |
[Effectiveness of regional lymphotropic therapy in combined treatment of tuberculosis in adolescents].
Topics: Adolescent; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Guinea Pigs; Humans; Injections, Intralymphatic; Isoniazid; Kanamycin; Male; Radiography; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1996 |
[Rationale for the use of regional lymphotropic therapy in the management of tuberculosis in adolescents].
Topics: Adolescent; Antitubercular Agents; Axilla; Drug Therapy, Combination; Follow-Up Studies; Humans; Injections; Isoniazid; Kanamycin; Length of Stay; Lymph Nodes; Trachea; Treatment Outcome; Tuberculosis, Pulmonary | 1996 |
A resected case of Mycobacterium szulgai pulmonary disease.
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Thailand; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1998 |
[Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP].
Topics: Adenosine Triphosphate; Antitubercular Agents; Ethambutol; Evaluation Studies as Topic; Isoniazid; Kanamycin; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1998 |
[Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate].
Topics: Adenosine Triphosphate; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Isoniazid; Kanamycin; Luminescent Measurements; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1999 |
[Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Data Interpretation, Statistical; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2000 |
[Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Monitoring; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium bovis; Mycobacterium kansasii; Mycobacterium tuberculosis; Rifampin; Russia; Streptomycin | 2001 |
Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Bacterial Typing Techniques; DNA Fingerprinting; Drug Administration Schedule; Drug Resistance, Bacterial; Ethambutol; Female; Genetics, Microbial; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Pyrazinamide; Recurrence; Retrospective Studies; Rifampin; Streptomycin; Treatment Failure; Tuberculosis, Pulmonary | 2002 |
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
Streptomycin and isoniazid in experimental guinea pig tuberculosis infected with kanamycin resistant tubercle bacilli.
Topics: Bacillus; Guinea Pigs; Isoniazid; Kanamycin; Lacticaseibacillus casei; Streptomycin; Tuberculosis | 1958 |
[The action of streptomycin, kanamycin and isoniazid on the breakdown of ATP in mycobacteria].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Anti-Bacterial Agents; Antibiotics, Antitubercular; Humans; Isoniazid; Kanamycin; Mycobacterium; Phosphates; Streptomycin | 1960 |
Retreatment of pulmonary tuberculosis. Experiences with various combinations of pyrazinamide, cycloserine, and kanamycin in patients excreting tubercle bacilli resistant to both streptomycin and isoniazid.
Topics: Anti-Bacterial Agents; Bacillus; Cycloserine; Humans; Isoniazid; Kanamycin; Pyrazinamide; Retreatment; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1960 |
[Comparative experimental observations in vivo on the antitubercular activity of isoniazid, of kanamycin and of their association].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Isoniazid; Kanamycin; Tuberculosis | 1960 |
[Action of kanamycin alone and associated with isoniazid in experimental tuberculosis induced by streptomycin-resistant bacteria].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Isoniazid; Kanamycin; Streptomycin; Tuberculosis | 1960 |
[The chemotherapy of renal tuberculosis: statistical observation].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Humans; Isoniazid; Kanamycin; Kidney; Streptomycin; Sulfanilamide; Sulfanilamides; Sulfonamides; Tuberculosis; Tuberculosis, Renal | 1963 |
[The importance of medical treatment of pulmonary tuberculosis from a new viewpoint].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Dihydrostreptomycin Sulfate; Ethionamide; Iproniazid; Isoniazid; Kanamycin; Oxytetracycline; Pyrazinamide; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1962 |
[Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin].
Topics: Cycloserine; Ethionamide; Isoniazid; Kanamycin; Pyrazinamide; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1962 |
[Study on the resistance of tubercle bacilli. Summary of method and reading of results].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacillus; Drug Resistance, Microbial; Gram-Positive Bacteria; Isoniazid; Kanamycin; Lacticaseibacillus casei; Mycobacterium tuberculosis; Reading; Streptomycin | 1962 |
[EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacillus; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Pyrazinamide; Research; Streptomycin; Thiosemicarbazones | 1963 |
[SYMPOSIUM: COUNTER-MEASURES IN INTRACTABLE PULMONARY TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Pneumonectomy; Pyrazinamide; Streptomycin; Thiosemicarbazones; Tuberculosis, Pulmonary | 1963 |
EFFECT OF KANAMYCIN ON GENITOURINARY TUBERCULOSIS: RESULTS WITH A LOW-DOSAGE REGIMEN.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Drug Eruptions; Hearing Disorders; Hearing Tests; Hematology; Isoniazid; Kanamycin; Kidney Function Tests; Liver Function Tests; Toxicology; Tuberculosis; Tuberculosis, Urogenital | 1963 |
[THE PROBLEM OF INFECTION WITH DRUG-RESISTANT MICROORGANISMS-TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Japan; Kanamycin; Statistics as Topic; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1963 |
[CASE OF TYPHOBACILLOSIS ASSOCIATED WITH SERRATIA MARCESCENS INFECTION RUNNING A VERY UNUSUAL COURSE].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitoxins; Cardiac Glycosides; Chloramphenicol; Isoniazid; Kanamycin; Oleandomycin; Oxyphenbutazone; Running; Serratia marcescens; Streptomycin; Toxicology; Toxins, Biological; Typhoid Fever | 1963 |
[RESULTS OF TREATMENT FOR PULMONARY TUBERCULOSIS WITH PRIMARY DRUG RESISTANCE IN OUR SANATORIUM].
Topics: Bacteriological Techniques; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Japan; Kanamycin; Statistics as Topic; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[METHOD FOR EVALUATING THE STRENGTH OF SYNTHETIC ANTIBIOTICS IN THE BLOOD SERUM DURING CHEMOTHERAPY OF TUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Blood Chemical Analysis; Culture Media; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Research; Serum; Streptomycin; Tuberculosis | 1963 |
MODERN DRUG TREATMENT OF MYCOBACTERIAL DISEASES.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Humans; Isoniazid; Kanamycin; Oxytetracycline; Pyrazinamide; Streptomycin; Thioacetazone; Thiosemicarbazones; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1963 |
[STUDIES ON MYCOBACTERIAL SENSITIVITY TO ANTIBIOTICS AND CHEMOTHERAPEUTIC AGENTS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Chlortetracycline; Colistin; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Ethionamide; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Research; Streptomycin; Tetracycline; Tetrazolium Salts | 1963 |
[EXPERIMENTS IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS IN GUINEA PIGS WITH 4,4'-DIISOAMYLOXYTHIOCARBANILIDE (ISOXYL)].
Topics: Antitubercular Agents; Guinea Pigs; Isoniazid; Japan; Kanamycin; Pathology; Phenylthiourea; Streptomycin; Tuberculosis | 1963 |
RECENT ADVANCES IN TREATMENT OF ORGAN TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Child; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Mycobacterium Infections; Prednisone; Pyrazinamide; Streptomycin; Tuberculosis; Tuberculosis, Cardiovascular; Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Osteoarticular; Tuberculosis, Pleural; Tuberculosis, Pulmonary; Tuberculosis, Urogenital; Viomycin | 1964 |
(CHEMOTHERAPEUTIC ORIGINAL AND RE-TREATMENT OF PULMONARY TUBERCULOSIS.)
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Streptomycin; Sulfonamides; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[PULMONARY TUBERCULOSIS MISDIAGNOSED AS OTHER DISEASES].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Diagnosis, Differential; Ethionamide; Isoniazid; Kanamycin; Lung Neoplasms; Neoplasms; Pneumonectomy; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1963 |
[ON THE SUBJECT OF SURGICAL TREATMENT OF PATIENTS AFFLICTED WITH PULMONARY TUBERCULOSIS AND RESISTANT TO THE MAJOR ANTIBIOTICS. THE ROLE OF KANAMYCIN].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Kanamycin; Pneumonectomy; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
[OUR RESULTS IN CHEMO-ANTIBIOTIC THERAPY OF SILICOTUBERCULOSIS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Pyrazinamide; Silicotuberculosis; Streptomycin; Toxicology | 1963 |
[INTOLERANCE AND TOXICITY OF SUBSTITUTE ANTIBACTERIAL DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cycloserine; Ethionamide; Feeding and Eating Disorders; Hepatitis; Isoniazid; Joint Diseases; Kanamycin; Nausea; Psychoses, Substance-Induced; Psychotic Disorders; Pyrazinamide; Streptomycin; Toxicology; Vertigo; Viomycin | 1963 |
[ANTIBACTERIAL TREATMENT IN PATIENTS AFFLICTED WITH PULMONARY TUBERCULOSIS CAUSED BY MYCOBACTERIA RESISTANT TO THE MAJOR CHEMO-ANTIBIOTICS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Collapse Therapy; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Pneumonectomy; Pyrazinamide; Streptomycin; Tuberculosis, Pulmonary | 1963 |
[METHOD FOR EVALUATING ANTITUBERCULAR DRUGS BY THEIR DIFFUSION INTO DEEP CULTURES OF TUBERCLE BACILLI IN SEMISOLID AGAR MEDIA].
Topics: Agar; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacillus; Bacteriological Techniques; Culture Media; Immune Sera; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Oxygen; Research; Streptomycin; Viomycin | 1963 |
[STUDIES ON DIFFERENCES IN EXPRESSION OF THE IN VITRO ACTIVITY OF ANTITUBERCULAR AGENTS IN VARIOUS COLONY-COUNTABLE MEDIA. 1. DIFFERENCES IN THE ANTIBACTERIAL STRENGTH ON OGAWA'S 1-PERCENT MEDIUM, KIRCHNER'S AGAR SLANT, AND KIRCHNER'S SEMISOLID AGAR].
Topics: Agar; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Culture Media; Drug Resistance; Drug Resistance, Microbial; In Vitro Techniques; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Viomycin | 1963 |
[CONSERVATIVE TREATMENT OF PULMONARY TUBERCULOSIS DIFFICULT TO CURE IN ELDERLY PATIENTS UNFIT FOR SURGERY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Ethionamide; Geriatrics; Isoniazid; Japan; Kanamycin; Pathology; Statistics as Topic; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary | 1963 |
ANONYMOUS MYCOBACTERIA ISOLATED FROM CLINICAL SPECIMENS IN HONG KONG.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacteriological Techniques; China; Drug Resistance; Drug Resistance, Microbial; Hong Kong; Humans; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Pyrazinamide; Research; Streptomycin; Thiosemicarbazones | 1964 |
[COMPARISON OF A DETERMINATION OF DRUG RESISTANCE USING 1 PER CENT OGAWA MEDIUM AND LOEWENSTEIN-JENSEN MEDIUM (EXAMINATION OF SPUTUM)].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Culture Media; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Sputum; Streptomycin; Viomycin | 1964 |
[THE MEDICAL TREATMENT OF COMMON PULMONARY TUBERCULOSIS IN THE ADULT].
Topics: Adrenocorticotropic Hormone; Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Prednisone; Rest; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1964 |
[LOCAL ANTIBIOTIC THERAPY OF PULMONARY TUBERCULOSIS LESIONS (INTRABRONCHIAL INSTILLATIONS)].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Ethionamide; Isoniazid; Kanamycin; Neomycin; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[THE USE OF ANTIBACILLARY DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Pneumonectomy; Pyrazinamide; Streptomycin; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1964 |
[NEW COMBINATIONS OF ANTITUBERCULAR AGENTS IN THE TREATMENT OF RENAL TUBERCULOSIS].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethionamide; Isoniazid; Kanamycin; Nephrectomy; Nephritis; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Renal; Tuberculosis, Urogenital; Viomycin | 1964 |
[ASSOCIATION OF PULMONARY TUBERCULOSIS AND DIABETES MELLITUS].
Topics: Diabetes Mellitus; Humans; Hypoglycemic Agents; Insulin; Insulin, Long-Acting; Isoniazid; Kanamycin; Metabolism; Physiology; Radiography, Thoracic; Tolazamide; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
EFFECTIVENESS OF CAPREOMYCIN AGAINST EXPERIMENTAL TUBERCULOSIS OF MICE AND GUINEA PIGS.
Topics: Antitubercular Agents; Capreomycin; Guinea Pigs; Isoniazid; Kanamycin; Mice; Mycobacterium bovis; Pharmacology; Research; Streptomycin; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Pulmonary; Tuberculosis, Splenic | 1964 |
[THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1964 |
[ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Infective Agents; Antitubercular Agents; Bacteriology; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Phenylthiourea; Pyrazinamide; Statistics as Topic; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1964 |
PULMONARY TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Child; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethambutol; Ethionamide; Isoniazid; Kanamycin; Mycobacterium Infections; Pharmacology; Prognosis; Pyrazinamide; Streptomycin; Surgical Procedures, Operative; Thiosemicarbazones; Toxicology; Tuberculosis; Tuberculosis, Miliary; Tuberculosis, Pulmonary; Viomycin | 1964 |
COMPARISON OF THE DEGREE OF DRUG RESISTANCE BETWEEN "1 PER CENT OGAWA MEDIUM" AND "LOEWENSTEIN-JENSEN MEDIUM".
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Culture Media; Cycloserine; Dihydrostreptomycin Sulfate; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Phosphates; Viomycin | 1963 |
FURTHER OBSERVATIONS ON THE KANAMYCIN RESISTANCE IN TUBERCULOUS PATIENTS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Biomedical Research; Cycloserine; Drug Resistance, Microbial; Drug Therapy; Ethionamide; Isoniazid; Japan; Kanamycin; Kanamycin Resistance; Mycobacterium tuberculosis; Sputum; Streptomycin; Tuberculosis | 1964 |
[DRUG TREATMENT OF RENAL TUBERCULOSIS].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Dihydrostreptomycin Sulfate; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Oxytetracycline; Phenylthiourea; Pyrazinamide; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Renal; Viomycin | 1964 |
[CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Blood Glucose; Carbohydrate Metabolism; Cycloserine; Diabetes Mellitus; Drug Tolerance; Ethionamide; Humans; Isoniazid; Kanamycin; Pharmacology; Pyrazinamide; Rifamycins; Streptomycin; Thiosemicarbazones; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
TOXIC EPIDERMAL NECROLYSIS.
Topics: Amobarbital; Conjunctivitis; Drug Therapy; Humans; Isoniazid; Kanamycin; Phenytoin; Skin Diseases; Stevens-Johnson Syndrome; Toxicology | 1964 |
[CASE OF ENCEPHALOMYELORADICULONEURITIS FOLLOWING DIARRHEA].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Diarrhea; Drug Therapy; Encephalitis; Isoniazid; Kanamycin; Polyradiculopathy; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
ETHIONAMIDE-INDUCED HEPATITIS. A REVIEW WITH A REPORT OF AN ADDITIONAL CASE.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Biopsy; Chemical and Drug Induced Liver Injury; Cycloserine; Drug Hypersensitivity; Ethionamide; France; Hepatitis; Isoniazid; Japan; Kanamycin; Liver Function Tests; Oxytetracycline; Pathology; Prednisone; Streptomycin; Sulfisoxazole; Toxicology; Tuberculosis | 1964 |
RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Geriatrics; Hospitals, State; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1964 |
SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Bacillus; Cycloserine; Dihydrostreptomycin Sulfate; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethionamide; Geriatrics; Isoniazid; Kanamycin; Pyrazinamide; Sputum; Streptomycin; Thiosemicarbazones; Toxicology; Tuberculosis; Viomycin | 1964 |
[CHANGES IN THE SENSITIVITY TO CHEMOTHERAPY OF MYCOBACTERIUM TUBERCULOSIS IN ANIMAL ORGANISMS].
Topics: Animals; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Liver; Mice; Mycobacterium; Mycobacterium tuberculosis; Rats; Research; Tuberculosis; Tuberculosis, Avian | 1964 |
[TUBERCULOUS MENINGITIS WITH RESISTANT KOCH BACILLI; RECOVERY OWING TO CYCLOSERINE-PYRAZINAMIDE COMBINATION].
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Synergism; Drug Therapy; Ethionamide; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin; Tuberculosis; Tuberculosis, Meningeal | 1964 |
DRUG RESISTANCE IN PULMONARY TUBERCULOSIS; TREATMENT WITH ETHIONAMIDE IN VARIOUS DRUG COMBINATIONS.
Topics: Cycloserine; Drug Combinations; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Drug Tolerance; Ethionamide; Isoniazid; Kanamycin; Pyrazinamide; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Viomycin | 1965 |
CHEMOTHERAPY OF TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Classification; Cycloserine; Drug Therapy; Ethionamide; Isoniazid; Kanamycin; Oxytetracycline; Pyrazinamide; Rest; Social Isolation; Streptomycin; Surgical Procedures, Operative; Thiosemicarbazones; Toxicology; Tuberculosis; Viomycin | 1964 |
[DETERMINATION OF THE RESISTANCE OF TUBERCULOSIS BACTERIA IN THE SERIAL DILUTION TEST AND IN THE VERTICAL DIFFUSION TEST].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Pharmacology; Research; Streptomycin; Tuberculosis; Viomycin | 1965 |
THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethionamide; Hepatomegaly; Isoniazid; Kanamycin; Liver Function Tests; Pharmacology; Pyrazinamide; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin | 1965 |
"ACTUAL COUNT" METHOD FOR THE RESISTANCE TEST OF TUBERCLE BACILLI.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Bacillus; Culture Media; Dihydrostreptomycin Sulfate; Drug Resistance; Drug Resistance, Microbial; Ethionamide; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Pharmacology; Thioacetazone; Thiosemicarbazones | 1964 |
[Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
Topics: Adolescent; Anti-Bacterial Agents; Genotype; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[Bactericidal therapy in patients with tuberculosis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Chlortetracycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Recurrence; Rifampin; Streptomycin; Time Factors; Tuberculosis, Pulmonary | 2004 |
[Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ozone; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mycobacterium tuberculosis; Ozone; Radiography, Thoracic; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
[Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
Topics: Adolescent; Amikacin; Antitubercular Agents; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Male; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Topics: Antitubercular Agents; Bacteriological Techniques; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; India; Isoniazid; Kanamycin; Male; Microscopy, Fluorescence; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Prevalence; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2009 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2011 |
Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; South Africa; Streptomycin | 2011 |
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
Topics: Acetamides; Adult; Amikacin; Antitubercular Agents; Capreomycin; Drug-Related Side Effects and Adverse Reactions; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Infectious Disease Medicine; Isoniazid; Kanamycin; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin | 2011 |
Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
Topics: Antitubercular Agents; Colorimetry; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nitrate Reductase; Ofloxacin; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2012 |
φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.
Topics: Antitubercular Agents; Bacteriophages; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Promoter Regions, Genetic; Recombinant Proteins; Rifampin; Signal-To-Noise Ratio; Sputum; Tuberculosis, Pulmonary | 2012 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kanamycin; Male; Prevalence; Rifampin; South Africa; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; Biological Transport; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Escherichia coli; Ethambutol; Genotype; Isoniazid; Kanamycin; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Protein Structure, Secondary; Protein Structure, Tertiary; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis | 2013 |
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2013 |
Salvage therapy for multidrug-resistant tuberculosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Capreomycin; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Male; Moxifloxacin; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Salvage Therapy; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2014 |
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; Capreomycin; Genotype; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant | 2014 |
Performance of REBA MTB-XDR to detect extensively drug-resistant tuberculosis in an intermediate-burden country.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Genes, MDR; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Republic of Korea; Rifampin; Sputum; Streptomycin | 2015 |
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cameroon; Clofazimine; Cohort Studies; Confidence Intervals; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Isoniazid; Kanamycin; Male; Medication Adherence; Middle Aged; Odds Ratio; Prospective Studies; Prothionamide; Pyrazinamide; Risk Assessment; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2015 |
The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum | 2015 |
Drug-resistant tuberculosis plagues India.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Isoniazid; Kanamycin; Medication Adherence; Mycobacterium tuberculosis; Nonprescription Drugs; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action.
Topics: Antitubercular Agents; Ciprofloxacin; Flow Cytometry; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2016 |
Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
Topics: Adult; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Nitrate Reductase; Ofloxacin; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum | 2016 |
Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Butyric Acid; Cell Survival; Chlorocebus aethiops; Culture Media; Glucose; High-Throughput Screening Assays; Isoniazid; Kanamycin; Levofloxacin; Metabolic Networks and Pathways; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Small Molecule Libraries; Species Specificity; Structure-Activity Relationship; Vero Cells | 2016 |
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2016 |
Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.
Topics: Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moldova; Mutation; Mycobacterium tuberculosis; Rifampin; South Africa; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2016 |
A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
Topics: Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Humans; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.
Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genes, Bacterial; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Molecular Typing; Mutation; Mycobacterium tuberculosis; Promoter Regions, Genetic; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA | 2016 |
Surveillance for tuberculosis in a rural community in The Philippines.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Isoniazid; Kanamycin; Male; Middle Aged; Philippines; Population Surveillance; Prevalence; Prospective Studies; Public Health; Rifampin; Rural Population; Streptomycin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult | 2016 |
Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.
Topics: Alleles; Amikacin; Antitubercular Agents; Automation, Laboratory; DNA, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genes, Bacterial; Humans; Isoniazid; Kanamycin; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Point-of-Care Systems; Polymerase Chain Reaction; Sensitivity and Specificity | 2017 |
Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Seoul; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2017 |
Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Topics: Antitubercular Agents; DNA, Bacterial; Ethambutol; Female; Genotype; Humans; Isoniazid; Kanamycin; Laboratories; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Referral and Consultation; Rifampin; South Africa | 2017 |
Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
Topics: Antitubercular Agents; Clofazimine; Colony Count, Microbial; Computer Simulation; Diarylquinolines; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Host-Pathogen Interactions; Humans; Immunity, Innate; Isoniazid; Kanamycin; Macrophages; Microbial Sensitivity Tests; Models, Statistical; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Pyrazinamide; Time Factors; Tuberculosis, Multidrug-Resistant | 2018 |
Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
Topics: Adolescent; Adult; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gene Frequency; Genotype; Humans; Isoniazid; Kanamycin; Kenya; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
Topics: Adult; Antitubercular Agents; Decision Support Techniques; Disease Progression; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Linezolid; Lung; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tissue Distribution; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2019 |
Evaluation of Thin Layer Agar 7H11 for Direct Susceptibility Testing of Mycobacterium Tuberculosis Complex against Second Line Anti Tuberculosis Drugs on Smear Positive Specimens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Bacteriological Techniques; Chromatography, Thin Layer; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Sensitivity and Specificity; Sputum; Tuberculosis; Young Adult | 2019 |
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Iran; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2020 |
Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan.
Topics: Antibiotics, Antitubercular; Capreomycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Uzbekistan | 2021 |
Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.
Topics: Acetyltransferases; Adult; Amidohydrolases; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Multivariate Analysis; Mutation; Mutation Rate; Mycobacterium tuberculosis; Odds Ratio; Ofloxacin; Prospective Studies; Rifampin; Sequence Analysis, DNA; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2021 |
Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria.
Topics: Colony Count, Microbial; Flow Cytometry; Humans; Immunologic Tests; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2021 |
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study.
Topics: Adult; Amikacin; Australia; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Use of Whole-Genome Sequencing to Predict
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS.
Topics: Amikacin; Antitubercular Agents; China; Drug Resistance; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nucleotides; Ofloxacin; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Lymph Node | 2022 |
Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2022 |
A NiCoT family metal transporter of
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cobalt; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Ethambutol; Gentamicins; Isoleucine; Isoniazid; Kanamycin; Leucine; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nalidixic Acid; Neomycin; Nickel; Norfloxacin; Ofloxacin | 2022 |
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant | 2023 |
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing | 2023 |